Results 11 to 20 of about 357,928 (304)

Smouldering multiple sclerosis: the ‘real MS’ [PDF]

open access: yesTherapeutic Advances in Neurological Disorders, 2022
Using a philosophical approach or deductive reasoning, we challenge the dominant clinico-radiological worldview that defines multiple sclerosis (MS) as a focal inflammatory disease of the central nervous system (CNS).
Gavin Giovannoni   +17 more
doaj   +13 more sources

Familial Incidence of Multiple Sclerosis (MS)

open access: yesPediatric Neurology Briefs, 1988
Age-adjusted familial rates for MS were determined in children and siblings of patients studied at the MS Clinic and Dept of Genetics, Health Sciences Centre Hospital, Univ British Columbia, Vancouver BC, Canada.
J Gordon Millichap
doaj   +3 more sources

Efficacy and Safety of Alemtuzumab in Patients of African Descent with Relapsing-Remitting Multiple Sclerosis: 8-Year Follow-up of CARE-MS I and II (TOPAZ Study)

open access: yesNeurology and Therapy, 2019
Introduction Multiple sclerosis (MS) patients of African descent have increased risk for disease progression and may be less responsive to disease-modifying therapy.
Annette F. Okai   +10 more
doaj   +1 more source

Real-World Safety and Effectiveness of Dimethyl Fumarate in Black or African American Patients with Multiple Sclerosis: 3-Year Results from ESTEEM

open access: yesNeurology and Therapy, 2020
Introduction Black or African American (black/AA) patients with multiple sclerosis (MS) are reported to exhibit greater disease severity compared with non-black or non-AA patients.
Mitzi J. Williams   +9 more
doaj   +1 more source

Development and evaluation of a website with patients experiences of multiple sclerosis: a mixed methods study

open access: yesBMC Neurology, 2022
Background A variety of management options (e.g., disease-modifying therapy, lifestyle interventions, rehabilitation) are available for persons with relapsing-remitting multiple sclerosis (MS).
Anna Sippel   +8 more
doaj   +1 more source

Sudden hearing loss as an early detector of multiple sclerosis: a systematic review [PDF]

open access: yes, 2018
To evaluate whether Sudden Sensorineural Hearing Loss (S-SNHL) may be an early symptom of Multiple Sclerosis (MS). A systematic review was conducted using the following keywords: "Multiple sclerosis, hearing loss, sudden hearing loss, vertigo, tinnitus ...
Bernitsas, E   +7 more
core   +1 more source

A Case of Neuromyelitis Optica: Puerto Rican Woman with an Increased Time Lag to Diagnosis and a High Response to Eculizumab Therapy

open access: yesCase Reports in Neurological Medicine, 2022
A link between intractable hiccups, as the initial symptom, and a possible neuromyelitis optica spectrum disorder (NMOSD) diagnosis is confusing but vital and may not be made by health care providers (HCPs) if they are not aware of the 2015 NMOSD ...
Ramón Vega   +7 more
doaj   +1 more source

Arbeiten zur Optischen Kohärenztomographie, Magnetresonanzspektroskopie und Ultrahochfeld-Magnetresonanztomographie [PDF]

open access: yes, 2019
Abstrakt (Deutsch) Hintergrund: Die Multiple Sklerose ist eine der häufigsten neurologischen Erkrankungen, die zu Behinderung bereits im jungen Erwachsenenalter führen kann.
Pfüller, Caspar Friedrich
core   +1 more source

Bayesian P-Splines to investigate the impact of covariates on Multiple Sclerosis clinical course [PDF]

open access: yes, 2003
This paper aims at proposing suitable statistical tools to address heterogeneity in repeated measures, within a Multiple Sclerosis (MS) longitudinal study.
Di Serio, C., Lamina, C.
core   +1 more source

Is There a Need to Differentiate Atypical Multiple Sclerosis from Neuromyelitis Optica Spectrum Disorders (NMOSD)? The Pros and Cons: A Systematic Review (PP-21) [PDF]

open access: yesNeurology Letters, 2023
Introduction: Most atypical inflammatory demyelinating diseases (IDD) exhibit pathological characteristics comparable to multiple sclerosis (MS). We conducted this systematic review to investigate the atypical cases that appear to be intermediate between
Sepideh Paybast   +3 more
doaj  

Home - About - Disclaimer - Privacy